Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Ballif, Marie"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-19 z 19
    Tytuł:
    Back-to-Africa introductions of Mycobacterium tuberculosis as the main cause of tuberculosis in Dar es Salaam, Tanzania.
    Autorzy:
    Zwyer M; Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.
    Rutaihwa LK; Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.; Department of Intervention and Clinical Trials, Ifakara Health Institute, Bagamoyo, Tanzania.
    Windels E; Department of Biosystems Science and Engineering, ETH Zürich, Basel, Switzerland.; Swiss Institute of Bioinformatics, Lausanne, Switzerland.
    Hella J; Department of Intervention and Clinical Trials, Ifakara Health Institute, Bagamoyo, Tanzania.
    Menardo F; Department of Plant and Microbial Biology, University of Zürich, Zürich, Switzerland.
    Sasamalo M; Department of Intervention and Clinical Trials, Ifakara Health Institute, Bagamoyo, Tanzania.
    Sommer G; Institut für Radiologie und Nuklearmedizin, Hirslanden Klinik St. Anna, Luzern, Switzerland.
    Schmülling L; Klinik für Radiologie und Nuklearmedizin, Department Theragnostik, Universitätsspital Basel, Basel, Switzerland.
    Borrell S; Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.
    Reinhard M; Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.
    Dötsch A; Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.
    Hiza H; Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.; Department of Intervention and Clinical Trials, Ifakara Health Institute, Bagamoyo, Tanzania.
    Stritt C; Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.
    Sikalengo G; Department of Intervention and Clinical Trials, Ifakara Health Institute, Bagamoyo, Tanzania.; St. Francis Referral Hospital, Ifakara, Tanzania.
    Fenner L; Institute for Social and Preventive Medicine, University of Bern, Bern, Switzerland.
    De Jong BC; Unit of Mycobacteriology, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
    Kato-Maeda M; Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, California, United States of America.
    Jugheli L; Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.
    Ernst JD; Division of Experimental Medicine, Department of Medicine, University of California, San Francisco, California, United States.
    Niemann S; Molecular and Experimental Mycobacteriology, Borstel Research Centre, Borstel, Germany.
    Jeljeli L; Molecular and Experimental Mycobacteriology, Borstel Research Centre, Borstel, Germany.
    Ballif M; Institute for Social and Preventive Medicine, University of Bern, Bern, Switzerland.
    Egger M; Institute for Social and Preventive Medicine, University of Bern, Bern, Switzerland.; Centre for Infectious Disease Research and Epidemiology, University of Cape Town, Cape Town, South Africa.; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
    Rakotosamimanana N; Institut Pasteur de Madagascar, Antananarivo, Madagascar.
    Yeboah-Manu D; Bacteriology Department, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Accra, Ghana.
    Asare P; Bacteriology Department, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Accra, Ghana.
    Malla B; Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.
    Dou HY; National Institute of Infectious Diseases and Vaccinology, National Health Research Institute, Zhunan, Taiwan.
    Zetola N; Botswana-UPenn Partnership, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
    Wilkinson RJ; Wellcome Center for Infectious Diseases Research in Africa, Cape Town, South Africa.; Francis Crick Institute, London, United Kingdom.
    Cox H; Institute of Infectious Diseases and Molecular Medicine and the Wellcome Centre for Infectious Disease Research in Africa, University of Cape Town, Cape Town, South Africa.
    Carter EJ; Division of Pulmonary and Critical Care Medicine, Warren Alpert School of Medicine at Brown University, Providence, Rhode Island, United States of America.
    Gnokoro J; Centre de Prise en Charge de Recherche et de Formation, Abidjan, Côte d'Ivoire.
    Yotebieng M; Division of General Internal Medicine, Department of Medicine, Albert Einstein College of Medicine, New York, New York, United States of America.
    Gotuzzo E; Instituto de Medicina Tropical 'Alexander von Humboldt', Universidad Peruana Cayetano Heredia, Lima, Perú.
    Abimiku A; Institute of Human Virology (IHVN), Abuja, Nigeria.
    Avihingsanon A; HIV-NAT, Thai Red Cross AIDS Research Centre and Center of Excellence in Tuberculosis, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
    Xu ZM; Swiss Institute of Bioinformatics, Lausanne, Switzerland.; School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
    Fellay J; Swiss Institute of Bioinformatics, Lausanne, Switzerland.; School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.; Precision Medicine Unit, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
    Portevin D; Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.
    Reither K; University of Basel, Basel, Switzerland.; Department of Medicine, Swiss Tropical and Public Health Institute, Basel, Switzerland.
    Stadler T; Department of Biosystems Science and Engineering, ETH Zürich, Basel, Switzerland.; Swiss Institute of Bioinformatics, Lausanne, Switzerland.
    Gagneux S; Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.
    Brites D; Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.
    Pokaż więcej
    Źródło:
    PLoS pathogens [PLoS Pathog] 2023 Apr 04; Vol. 19 (4), pp. e1010893. Date of Electronic Publication: 2023 Apr 04 (Print Publication: 2023).
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Mycobacterium tuberculosis*/genetics
    Tuberculosis*/epidemiology
    Humans ; Tanzania/epidemiology ; Genotype ; Virulence
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Design and implementation of a global site assessment survey among HIV clinics participating in the International epidemiology Databases to Evaluate AIDS (IeDEA) research consortium.
    Autorzy:
    Brazier E; City University of New York, Institute for Implementation Science in Population Health, New York, NY, United States of America.; City University of New York, Graduate School of Public Health and Health Policy, New York, NY, United States of America.
    Maruri F; Department of Medicine, Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN, United States of America.
    Wester CW; Department of Medicine, Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN, United States of America.; Vanderbilt Institute for Global Health, Nashville, TN, United States of America.
    Musick B; School of Medicine, Indiana University, Indianapolis, IN, United States of America.
    Freeman A; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States of America.
    Parcesepe A; Department of Maternal and Child Health, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.
    Hossmann S; Institute of Social and Preventive Medicine, University of Berne, Berne, Switzerland.
    Christ B; Institute of Social and Preventive Medicine, University of Berne, Berne, Switzerland.
    Kimmel A; Department of Health Behavior and Policy, Virginia Commonwealth University School of Medicine/VCU Health, Richmond, VA, United States of America.
    Humphrey J; Division of Infectious Diseases, Department of Medicine, Indiana University, Indianapolis, IN, United States of America.
    Freeman E; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States of America.
    Enane LA; The Ryan White Center for Pediatric Infectious Disease and Global Health, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, United States of America.
    Lancaster KE; Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH, United States of America.
    Ballif M; Institute of Social and Preventive Medicine, University of Berne, Berne, Switzerland.
    Golub JE; Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
    Nash D; City University of New York, Institute for Implementation Science in Population Health, New York, NY, United States of America.; City University of New York, Graduate School of Public Health and Health Policy, New York, NY, United States of America.
    Duda SN; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, United States of America.
    Pokaż więcej
    Corporate Authors:
    International epidemiology Databases to Evaluate AIDS (IeDEA) consortium
    Źródło:
    PloS one [PLoS One] 2023 Mar 14; Vol. 18 (3), pp. e0268167. Date of Electronic Publication: 2023 Mar 14 (Print Publication: 2023).
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural
    MeSH Terms:
    Acquired Immunodeficiency Syndrome*/diagnosis
    Acquired Immunodeficiency Syndrome*/drug therapy
    Acquired Immunodeficiency Syndrome*/epidemiology
    COVID-19*/epidemiology
    HIV Infections*/diagnosis
    HIV Infections*/drug therapy
    HIV Infections*/epidemiology
    Tuberculosis*
    Pregnancy ; Adolescent ; Humans ; Female ; Child ; Cross-Sectional Studies ; Surveys and Questionnaires
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Impact of the COVID-19 pandemic on TB services at ART programmes in low- and middle-income countries: a multi-cohort survey.
    Autorzy:
    Marti M; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
    Zürcher K; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
    Enane LA; The Ryan White Center for Pediatric Infectious Disease and Global Health, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
    Diero L; Department of Medicine, Moi University School of Medicine, Eldoret, Kenya.; Department of Medicine, Moi Teaching and Referral Hospital, Eldoret, Kenya.
    Marcy O; University of Bordeaux, Inserm U1219, IRD EMR271, Bordeaux, France.
    Tiendrebeogo T; University of Bordeaux, Inserm U1219, IRD EMR271, Bordeaux, France.
    Yotebieng M; Division of General Internal Medicine, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA.
    Twizere C; Centre National de Référence en matière de VIH/SIDA Burundi (CNR), Bujumbura, Burundi.
    Khusuwan S; Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand.
    Yunihastuti E; Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.
    Reubenson G; Rahima Moosa Mother and Child Hospital, Department of Paediatrics and Child Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
    Shah NS; Emory Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
    Egger M; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.; Centre for Infectious Disease Epidemiology and Research, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
    Ballif M; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
    Fenner L; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
    Pokaż więcej
    Corporate Authors:
    IeDEA global consortium; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
    Źródło:
    Journal of the International AIDS Society [J Int AIDS Soc] 2022 Oct; Vol. 25 (10), pp. e26018.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
    MeSH Terms:
    HIV Infections*/diagnosis
    HIV Infections*/drug therapy
    HIV Infections*/epidemiology
    COVID-19*/epidemiology
    Tuberculosis*/diagnosis
    Tuberculosis*/drug therapy
    Tuberculosis*/epidemiology
    Disinfectants*/therapeutic use
    Humans ; Pandemics ; Developing Countries ; Surveys and Questionnaires
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Availability and experiences of differentiated antiretroviral therapy delivery at HIV care facilities in rural Zimbabwe: a mixed-method study.
    Autorzy:
    Christ B; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
    van Dijk JH; SolidarMed, Masvingo, Zimbabwe.
    Nyandoro TY; SolidarMed, Masvingo, Zimbabwe.
    Reichmuth ML; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
    Kunzekwenyika C; SolidarMed, Masvingo, Zimbabwe.
    Chammartin F; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
    Egger M; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.; Centre for Infectious Disease Research and Epidemiology, University of Cape Town, Cape Town, South Africa.; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
    Wringe A; London School of Hygiene and Tropical Medicine, London, UK.
    Ballif M; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
    Pokaż więcej
    Corporate Authors:
    International epidemiology Databases to Evaluate AIDS in Southern Africa (IeDEA-SA)
    Źródło:
    Journal of the International AIDS Society [J Int AIDS Soc] 2022 Aug; Vol. 25 (8), pp. e25944.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
    MeSH Terms:
    Anti-HIV Agents*/therapeutic use
    HIV Infections*/drug therapy
    Cross-Sectional Studies ; Focus Groups ; Humans ; Zimbabwe
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Global HIV mortality trends among children on antiretroviral treatment corrected for under-reported deaths: an updated analysis of the International epidemiology Databases to Evaluate AIDS collaboration.
    Autorzy:
    Kassanjee R; Centre for Infectious Disease Epidemiology and Research (CIDER), School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
    Johnson LF; Centre for Infectious Disease Epidemiology and Research (CIDER), School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
    Zaniewski E; Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
    Ballif M; Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
    Christ B; Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
    Yiannoutsos CT; Richard M. Fairbanks School of Public Health, Indiana University, Indianapolis, Indiana, USA.
    Nyakato P; Centre for Infectious Disease Epidemiology and Research (CIDER), School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
    Desmonde S; Centre d'Epidémiologie et de Recherche en santé des Populations (CERPOP), Inserm U1027/University Toulouse 3, Toulouse, France.
    Edmonds A; Department of Epidemiology, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
    Sudjaritruk T; Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.; Clinical and Molecular Epidemiology of Emerging and Re-emerging Infectious Diseases Research Cluster, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
    Pinto J; School of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil.
    Vreeman R; Department of Global Health and Health System Design, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Arnhold Institute for Global Health, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Academic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya.
    Dahourou DL; Centre d'Epidémiologie et de Recherche en santé des Populations (CERPOP), Inserm U1027/University Toulouse 3, Toulouse, France.; Département Biomédical/Santé Publique, Institut de Recherche en Sciences de la Santé, Ouagadougou, Burkina Faso.
    Twizere C; CA-IeDEA Burundi, Centre National de Référence en matière de VIH/SIDA (CNR), Bujumbura, Burundi.
    Kariminia A; Kirby Institute, UNSW Sydney, Sydney, Australia.
    Carlucci JG; Ryan White Center for Pediatric Infectious Diseases and Global Health, Indiana University School of Medicine, Indianapolis, Indiana, USA.
    Kasozi C; Masaka Regional Referral Hospital, Masaka, Uganda.
    Davies MA; Centre for Infectious Disease Epidemiology and Research (CIDER), School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
    Pokaż więcej
    Corporate Authors:
    International epidemiology Databases to Evaluate AIDS (IeDEA) Collaboration
    Źródło:
    Journal of the International AIDS Society [J Int AIDS Soc] 2021 Sep; Vol. 24 Suppl 5, pp. e25780.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural
    MeSH Terms:
    Acquired Immunodeficiency Syndrome*/drug therapy
    Anti-HIV Agents*/therapeutic use
    HIV Infections*/drug therapy
    HIV Infections*/epidemiology
    Adolescent ; Africa, Southern ; Anti-Retroviral Agents/therapeutic use ; Child ; Cohort Studies ; Humans
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Diagnosis and clinical outcomes of extrapulmonary tuberculosis in antiretroviral therapy programmes in low- and middle-income countries: a multicohort study.
    Autorzy:
    Zürcher K; Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
    Ballif M; Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
    Kiertiburanakul S; Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
    Chenal H; Centre Intégré de Recherches Biocliniques d'Abidjan (CIRBA), Abidjan, Côte d'Ivoire.
    Yotebieng M; College of Public Health, The Ohio State University, Columbus, OH, USA.
    Grinsztejn B; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
    Michael D; National Institute for Medical Research, Kisesa HDSS, Mwanza, Tanzania.
    Sterling TR; Vanderbilt Tuberculosis Center, Nashville, TN, USA.; Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN, USA.
    Ngonyani KM; Tumbi Special Hospital, CTC, Kibaha Town, Tanzania.
    Mandalakas AM; The Global Tuberculosis Program, Texas Children's Hospital and Baylor College of Medicine, Houston, TX, USA.
    Egger M; Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.; Centre for Infectious Disease Epidemiology & Research, School of Public Health & Family Medicine, University of Cape Town, South Africa.
    Pettit AC; Vanderbilt Tuberculosis Center, Nashville, TN, USA.; Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN, USA.
    Fenner L; Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
    Pokaż więcej
    Corporate Authors:
    International Epidemiology Databases to Evaluate AIDS (IeDEA) consortium
    Źródło:
    Journal of the International AIDS Society [J Int AIDS Soc] 2019 Sep; Vol. 22 (9), pp. e25392.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural
    MeSH Terms:
    AIDS-Related Opportunistic Infections/*diagnosis
    HIV Infections/*complications
    Tuberculosis/*diagnosis
    AIDS-Related Opportunistic Infections/etiology ; AIDS-Related Opportunistic Infections/mortality ; Adult ; Anti-HIV Agents/administration & dosage ; Asia ; Caribbean Region ; Cohort Studies ; Developing Countries ; Female ; HIV Infections/drug therapy ; HIV Infections/economics ; Humans ; Logistic Models ; Male ; Poverty ; South America ; Tuberculosis/epidemiology ; Tuberculosis/etiology ; Tuberculosis/mortality
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    HIV viral load as an independent risk factor for tuberculosis in South Africa: collaborative analysis of cohort studies.
    Autorzy:
    Fenner L; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.; Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.
    Atkinson A; Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.
    Boulle A; Khayelitsha ART Programme, Médecins Sans Frontières, Cape Town, South Africa.
    Fox MP; Health Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Departments of Epidemiology and Global Health, Boston University, Boston, MA, USA.
    Prozesky H; Division of Infectious Diseases, Department of Medicine, University of Stellenbosch and Tygerberg Hospital, Cape Town, South Africa.
    Zürcher K; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
    Ballif M; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
    Furrer H; Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.
    Zwahlen M; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
    Davies MA; Centre for Infectious Disease Epidemiology and Research (CIDER), School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
    Egger M; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.; Centre for Infectious Disease Epidemiology and Research (CIDER), School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
    Pokaż więcej
    Corporate Authors:
    International Epidemiology Database to Evaluate AIDS in Southern Africa (IeDEA-SA)
    Źródło:
    Journal of the International AIDS Society [J Int AIDS Soc] 2017 Jun 23; Vol. 20 (1), pp. 21327.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Viral Load*
    HIV Infections/*complications
    Tuberculosis, Pulmonary/*complications
    Adult ; CD4 Lymphocyte Count ; CD4-Positive T-Lymphocytes ; Cohort Studies ; Female ; HIV Infections/drug therapy ; Humans ; Incidence ; Male ; Middle Aged ; Risk Factors ; Serologic Tests ; South Africa/epidemiology ; Tuberculosis, Pulmonary/epidemiology ; Tuberculosis, Pulmonary/virology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Influenza Pandemics and Tuberculosis Mortality in 1889 and 1918: Analysis of Historical Data from Switzerland.
    Autorzy:
    Zürcher K; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
    Zwahlen M; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
    Ballif M; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
    Rieder HL; Epidemiology, Biostatistics and Prevention Institute, University of Zürich, Zürich, Switzerland.
    Egger M; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
    Fenner L; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2016 Oct 05; Vol. 11 (10), pp. e0162575. Date of Electronic Publication: 2016 Oct 05 (Print Publication: 2016).
    Typ publikacji:
    Historical Article; Journal Article
    MeSH Terms:
    Influenza, Human/*epidemiology
    Tuberculosis/*mortality
    Databases, Factual ; History, 19th Century ; History, 20th Century ; Humans ; Influenza, Human/complications ; Pandemics/history ; Poisson Distribution ; Russia/epidemiology ; Seasons ; Spain/epidemiology ; Survival Analysis ; Switzerland ; Tuberculosis/etiology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Implementation of Tuberculosis Intensive Case Finding, Isoniazid Preventive Therapy, and Infection Control ("Three I's") and HIV-Tuberculosis Service Integration in Lower Income Countries.
    Autorzy:
    Charles MK; Vanderbilt Univ. School of Medicine, Vanderbilt Institute for Global Health (VIGH), Nashville, Tennessee, United States of America.
    Lindegren ML; Vanderbilt Univ. School of Medicine, Vanderbilt Institute for Global Health (VIGH), Nashville, Tennessee, United States of America.
    Wester CW; Vanderbilt Univ. School of Medicine, Vanderbilt Institute for Global Health (VIGH), Nashville, Tennessee, United States of America.
    Blevins M; Vanderbilt Univ. School of Medicine, Vanderbilt Institute for Global Health (VIGH), Nashville, Tennessee, United States of America.
    Sterling TR; Vanderbilt Univ. School of Medicine, Vanderbilt Institute for Global Health (VIGH), Nashville, Tennessee, United States of America.
    Dung NT; National Hospital of Tropical Diseases, Hanoi, Vietnam.
    Dusingize JC; Women's Equity in Access to Care & Treatment, Kigali, Rwanda.
    Avit-Edi D; MTCTPlus, Abidjan, Cote d'Ivoire.
    Durier N; TREAT Asia, amfAR-The Foundation for AIDS Research, Bangkok, Thailand.
    Castelnuovo B; Infectious Disease Institute, Kampala, Uganda.
    Nakigozi G; Rakai Health Sciences Program, Kalisizo, Uganda.
    Cortes CP; University of Chile School of Medicine, Santiago, Chile.
    Ballif M; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
    Fenner L; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.
    Pokaż więcej
    Corporate Authors:
    International epidemiology Databases to Evaluate AIDS (IeDEA) Collaboration
    Źródło:
    PloS one [PLoS One] 2016 Apr 13; Vol. 11 (4), pp. e0153243. Date of Electronic Publication: 2016 Apr 13 (Print Publication: 2016).
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural
    MeSH Terms:
    Infection Control*
    AIDS-Related Opportunistic Infections/*diagnosis
    AIDS-Related Opportunistic Infections/*prevention & control
    Antitubercular Agents/*therapeutic use
    HIV Infections/*drug therapy
    Isoniazid/*therapeutic use
    Tuberculosis/*diagnosis
    Tuberculosis/*prevention & control
    AIDS-Related Opportunistic Infections/drug therapy ; Africa ; Asia ; Caribbean Region ; HIV Infections/complications ; Humans ; Poverty ; South America ; Tuberculosis/drug therapy ; World Health Organization
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Tuberculosis Mortality and Living Conditions in Bern, Switzerland, 1856-1950.
    Autorzy:
    Zürcher K; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
    Ballif M; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.
    Zwahlen M; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
    Rieder HL; Epidemiology, Biostatistics and Prevention Institute, University of Zürich, Zürich, Switzerland.
    Egger M; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
    Fenner L; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2016 Feb 16; Vol. 11 (2), pp. e0149195. Date of Electronic Publication: 2016 Feb 16 (Print Publication: 2016).
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Social Conditions*
    Tuberculosis/*mortality
    Cities ; Humans ; Public Health ; Switzerland/epidemiology ; Tuberculosis/prevention & control
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Tuberculosis in Pediatric Antiretroviral Therapy Programs in Low- and Middle-Income Countries: Diagnosis and Screening Practices.
    Autorzy:
    Ballif M; Institute of Social and Preventive Medicine (ISPM), University of Bern, Switzerland.
    Renner L; University of Ghana Medical School, Korle Bu, Accra.
    Claude Dusingize J; Women's Equity in Access to Care & Treatment, Kigali, Rwanda.
    Leroy V; Inserm, U897, Epidémiologie-Biostatistiques ISPED, University of Bordeaux, France.
    Ayaya S; Department of Child Health and Pediatrics, Moi University School of Medicine, Kenya.
    Wools-Kaloustian K; Indiana University School of Medicine.
    Cortes CP; University of Chile School of Medicine, Santiago.
    McGowan CC; Vanderbilt University School of Medicine, Nashville, Tennessee.
    Graber C; Institute of Social and Preventive Medicine (ISPM), University of Bern, Switzerland.
    Mandalakas AM; Tuberculosis Initiative, Texas Children's Hospital, and Baylor College of Medicine, Houston.
    Mofenson LM; Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland.
    Egger M; Institute of Social and Preventive Medicine (ISPM), University of Bern, Switzerland.
    Kumara Wati KD; Sanglah Hospital, Udayana University, Bali, Indonesia.
    Nallusamy R; Penang Hospital, Malaysia.
    Reubenson G; Rahima Moosa Mother and Child Hospital, Department of Pediatrics and Child Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
    Davies MA; Centre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, University of Cape Town, South Africa.
    Fenner L; Institute of Social and Preventive Medicine (ISPM), University of Bern, Switzerland Swiss Tropical and Public Health Institute, Basel, Switzerland University of Basel, Switzerland.
    Pokaż więcej
    Corporate Authors:
    International Epidemiologic Databases to Evaluate AIDS (IeDEA)
    International Epidemiologic Databases to Evaluate AIDS IeDEA
    Źródło:
    Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2015 Mar; Vol. 4 (1), pp. 30-8. Date of Electronic Publication: 2014 Mar 28.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural
    MeSH Terms:
    Anti-HIV Agents/*economics
    Anti-HIV Agents/*therapeutic use
    Tuberculosis/*diagnosis
    Tuberculosis/*economics
    Africa South of the Sahara ; Americas ; Asia ; Child ; Child, Preschool ; Developing Countries ; HIV Infections/complications ; HIV Infections/drug therapy ; HIV Infections/economics ; Humans ; Infant ; Microscopy/economics ; Microscopy/methods ; Mycobacterium tuberculosis/isolation & purification ; Poverty ; Radiography, Thoracic/economics ; Radiography, Thoracic/methods ; Sputum/microbiology ; Tuberculosis/complications ; Tuberculosis/drug therapy
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage.
    Autorzy:
    Merker M; Molecular Mycobacteriology, Research Center Borstel, Borstel, Germany.
    Blin C; 1] Laboratoire Biologie Intégrative des Population, Evolution Moléculaire, Ecole Pratique des Hautes Etudes, Paris, France. [2] Institut de Systématique, Evolution, Biodiversité, UMR-CNRS 7205, Muséum National d'Histoire Naturelle, Université Pierre et Marie Curie, Ecole Pratique des Hautes Etudes, Sorbonne Universités, Paris, France.
    Mona S; 1] Laboratoire Biologie Intégrative des Population, Evolution Moléculaire, Ecole Pratique des Hautes Etudes, Paris, France. [2] Institut de Systématique, Evolution, Biodiversité, UMR-CNRS 7205, Muséum National d'Histoire Naturelle, Université Pierre et Marie Curie, Ecole Pratique des Hautes Etudes, Sorbonne Universités, Paris, France.
    Duforet-Frebourg N; Université Joseph Fourier, Centre National de la Recherche Scientifique, Laboratoire Techniques de l'Ingénierie Médicale et de la Complexité-Informatique, Mathématiques et Applications, Grenoble, France.
    Lecher S; 1] INSERM U1019, Center for Infection and Immunity of Lille, Lille, France. [2] Centre National de la Recherche Scientifique, UMR 8204, Lille, France. [3] Université Lille Nord, Center for Infection and Immunity of Lille, Lille, France. [4] Institut Pasteur de Lille, Center for Infection and Immunity of Lille, Lille, France.
    Willery E; 1] INSERM U1019, Center for Infection and Immunity of Lille, Lille, France. [2] Centre National de la Recherche Scientifique, UMR 8204, Lille, France. [3] Université Lille Nord, Center for Infection and Immunity of Lille, Lille, France. [4] Institut Pasteur de Lille, Center for Infection and Immunity of Lille, Lille, France.
    Blum MG; Université Joseph Fourier, Centre National de la Recherche Scientifique, Laboratoire Techniques de l'Ingénierie Médicale et de la Complexité-Informatique, Mathématiques et Applications, Grenoble, France.
    Rüsch-Gerdes S; National Reference Center for Mycobacteria, Research Center Borstel, Borstel, Germany.
    Mokrousov I; Laboratory of Molecular Microbiology, St. Petersburg Pasteur Institute, St. Petersburg, Russia.
    Aleksic E; Centre for Biomedical Research, Burnet Institute, Melbourne, Victoria, Australia.
    Allix-Béguec C; Genoscreen, Lille, France.
    Antierens A; Medical Department, Médecins sans Frontières Switzerland, Geneva, Switzerland.
    Augustynowicz-Kopeć E; Department of Microbiology, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland.
    Ballif M; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
    Barletta F; Instituto de Medicina Tropical Alexander von Humboldt, Molecular Epidemiology Unit-Tuberculosis, Universidad Peruana Cayetano Heredia, Lima, Peru.
    Beck HP; Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland.
    Barry CE 3rd; Tuberculosis Research Section, National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Bethesda, Maryland, USA.
    Bonnet M; Clinical Research Department, Epicentre, Paris, France.
    Borroni E; Emerging Bacterial Pathogens Unit, San Raffaele Scientific Institute, Milan, Italy.
    Campos-Herrero I; Department of Microbiology, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain.
    Cirillo D; Emerging Bacterial Pathogens Unit, San Raffaele Scientific Institute, Milan, Italy.
    Cox H; Division of Medical Microbiology, University of Cape Town, Cape Town, South Africa.
    Crowe S; 1] Centre for Biomedical Research, Burnet Institute, Melbourne, Victoria, Australia. [2] Department of Infectious Diseases, Alfred Hospital, Melbourne, Victoria, Australia. [3] Central Clinical School, Monash University, Melbourne, Victoria, Australia.
    Crudu V; National Tuberculosis Reference Laboratory, Phthysiopneumology Institute, Chisinau, Republic of Moldova.
    Diel R; Institute for Epidemiology, Schleswig-Holstein University Hospital, Kiel, Germany.
    Drobniewski F; 1] Public Health England National Mycobacterial Reference Laboratory and Clinical Tuberculosis and Human Immunodeficiency Virus Group, Queen Mary's School of Medicine and Dentistry, London, UK. [2] Department of Infectious Diseases, Imperial College, London, UK.
    Fauville-Dufaux M; Tuberculosis and Mycobacteria, Scientific Institute of Public Health, Brussels, Belgium.
    Gagneux S; Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland.
    Ghebremichael S; Department of Microbiology, Public Health Agency of Sweden, Solna, Sweden.
    Hanekom M; Department of Science and Technology/National Research Foundation, Centre of Excellence for Biomedical Tuberculosis Research/Medical Research Council, Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
    Hoffner S; Department of Diagnostics and Vaccinology, Swedish Institute for Communicable Disease Control, Solna, Sweden.
    Jiao WW; Key Laboratory of Major Diseases in Children and National Key Discipline of Pediatrics (Capital Medical University), Ministry of Education, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, Beijing, China.
    Kalon S; US Agency for International Development Quality Health Care Project, Bishkek, Kyrgyzstan.
    Kohl TA; Molecular Mycobacteriology, Research Center Borstel, Borstel, Germany.
    Kontsevaya I; Samara Oblast Tuberculosis Service, Samara, Russia.
    Lillebæk T; Statens Serum Institute, International Reference Laboratory of Mycobacteriology, Copenhagen, Denmark.
    Maeda S; Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan.
    Nikolayevskyy V; 1] Public Health England National Mycobacterial Reference Laboratory and Clinical Tuberculosis and Human Immunodeficiency Virus Group, Queen Mary's School of Medicine and Dentistry, London, UK. [2] Department of Infectious Diseases, Imperial College, London, UK.
    Rasmussen M; Statens Serum Institute, International Reference Laboratory of Mycobacteriology, Copenhagen, Denmark.
    Rastogi N; World Health Organization Supranational Tuberculosis Reference Laboratory, Institut Pasteur de la Guadeloupe, Abymes, France.
    Samper S; Instituto de Investigación Sanitaria Aragón, Hospital Universitario Miguel Servet, Zaragoza, Spain.
    Sanchez-Padilla E; Clinical Research Department, Epicentre, Paris, France.
    Savic B; Institute of Microbiology and Immunology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
    Shamputa IC; Tuberculosis Research Section, National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Bethesda, Maryland, USA.
    Shen A; Key Laboratory of Major Diseases in Children and National Key Discipline of Pediatrics (Capital Medical University), Ministry of Education, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, Beijing, China.
    Sng LH; Central Tuberculosis Laboratory, Department of Pathology, Singapore General Hospital, Singapore.
    Stakenas P; Department of Immunology and Cell Biology, Institute of Biotechnology, Vilnius University, Vilnius, Lithuania.
    Toit K; Tartu University Hospital United Laboratories, Mycobacteriology, Tartu, Estonia.
    Varaine F; Medical Department, Médecins sans Frontières, Paris, France.
    Vukovic D; Institute of Microbiology and Immunology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
    Wahl C; Genoscreen, Lille, France.
    Warren R; Department of Science and Technology/National Research Foundation, Centre of Excellence for Biomedical Tuberculosis Research/Medical Research Council, Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
    Supply P; 1] INSERM U1019, Center for Infection and Immunity of Lille, Lille, France. [2] Centre National de la Recherche Scientifique, UMR 8204, Lille, France. [3] Université Lille Nord, Center for Infection and Immunity of Lille, Lille, France. [4] Institut Pasteur de Lille, Center for Infection and Immunity of Lille, Lille, France. [5] Genoscreen, Lille, France.
    Niemann S; 1] Molecular Mycobacteriology, Research Center Borstel, Borstel, Germany. [2] German Center for Infection Research, Borstel Site, Borstel, Germany.
    Wirth T; 1] Laboratoire Biologie Intégrative des Population, Evolution Moléculaire, Ecole Pratique des Hautes Etudes, Paris, France. [2] Institut de Systématique, Evolution, Biodiversité, UMR-CNRS 7205, Muséum National d'Histoire Naturelle, Université Pierre et Marie Curie, Ecole Pratique des Hautes Etudes, Sorbonne Universités, Paris, France.
    Pokaż więcej
    Źródło:
    Nature genetics [Nat Genet] 2015 Mar; Vol. 47 (3), pp. 242-9. Date of Electronic Publication: 2015 Jan 19.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Mycobacterium tuberculosis/*classification
    Tuberculosis, Multidrug-Resistant/*microbiology
    Biological Evolution ; Evolution, Molecular ; Genome, Bacterial ; Genotype ; Global Health ; Humans ; Mutation ; Mycobacterium tuberculosis/genetics ; Mycobacterium tuberculosis/isolation & purification ; Phylogeny ; Tuberculosis, Multidrug-Resistant/epidemiology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Diversity of Mycobacterium tuberculosis and drug resistance in different provinces of Papua New Guinea.
    Autorzy:
    Ley SD; Swiss Tropical and Public Health Institute, Basel, Switzerland. .; University of Basel, Basel, Switzerland. .; Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea. .
    Harino P; Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea. .
    Vanuga K; Goroka Provincial Hospital, Goroka, Papua New Guinea. .
    Kamus R; Alotau Provincial Hospital, Alotau, Papua New Guinea. .
    Carter R; Queensland Mycobacterium Reference Laboratory, Pathology Queensland, Brisbane, Australia. .
    Coulter C; Queensland Mycobacterium Reference Laboratory, Pathology Queensland, Brisbane, Australia. .
    Pandey S; Queensland Mycobacterium Reference Laboratory, Pathology Queensland, Brisbane, Australia. .
    Feldmann J; Swiss Tropical and Public Health Institute, Basel, Switzerland. .; University of Basel, Basel, Switzerland. .
    Ballif M; Swiss Tropical and Public Health Institute, Basel, Switzerland. .; University of Basel, Basel, Switzerland. .
    Siba PM; Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea. .
    Phuanukoonnon S; Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea. .
    Gagneux S; Swiss Tropical and Public Health Institute, Basel, Switzerland. .; University of Basel, Basel, Switzerland. .
    Beck HP; Swiss Tropical and Public Health Institute, Basel, Switzerland. .; University of Basel, Basel, Switzerland. .
    Pokaż więcej
    Źródło:
    BMC microbiology [BMC Microbiol] 2014 Dec 05; Vol. 14, pp. 307. Date of Electronic Publication: 2014 Dec 05.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Drug Resistance, Bacterial*
    Genetic Variation*
    Mycobacterium tuberculosis/*classification
    Mycobacterium tuberculosis/*drug effects
    Tuberculosis/*microbiology
    Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antitubercular Agents/pharmacology ; Female ; Genotype ; Humans ; Male ; Microbial Sensitivity Tests ; Middle Aged ; Molecular Typing ; Mycobacterium tuberculosis/genetics ; Mycobacterium tuberculosis/isolation & purification ; Papua New Guinea/epidemiology ; Tuberculosis/epidemiology ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Tuberculosis in antiretroviral treatment programs in lower income countries: availability and use of diagnostics and screening.
    Autorzy:
    Fenner L; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland ; Swiss Tropical and Public Health Institute, Basel, Switzerland ; University of Basel, Basel, Switzerland.
    Ballif M
    Graber C
    Nhandu V
    Dusingize JC
    Cortes CP
    Carriquiry G
    Anastos K
    Garone D
    Jong E
    Gnokoro JC
    Sued O
    Ajayi S
    Diero L
    Wools-Kaloustian K
    Kiertiburanakul S
    Castelnuovo B
    Lewden C
    Durier N
    Sterling TR
    Egger M
    Pokaż więcej
    Corporate Authors:
    International epidemiological Databases to Evaluate AIDS (IeDEA)
    Źródło:
    PloS one [PLoS One] 2013 Oct 17; Vol. 8 (10), pp. e77697. Date of Electronic Publication: 2013 Oct 17 (Print Publication: 2013).
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural
    MeSH Terms:
    Tuberculosis/*diagnosis
    Tuberculosis/*drug therapy
    Adult ; Africa South of the Sahara/epidemiology ; Anti-Retroviral Agents/therapeutic use ; Asia/epidemiology ; Female ; Geography ; Humans ; Latin America/epidemiology ; Male ; Surveys and Questionnaires ; Tuberculosis/epidemiology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Drug resistance-conferring mutations in Mycobacterium tuberculosis from Madang, Papua New Guinea.
    Autorzy:
    Ballif M; Swiss Tropical and Public Health Institute, Socinstrasse 57, 4002 Basel, Switzerland.
    Harino P
    Ley S
    Coscolla M
    Niemann S
    Carter R
    Coulter C
    Borrell S
    Siba P
    Phuanukoonnon S
    Gagneux S
    Beck HP
    Pokaż więcej
    Źródło:
    BMC microbiology [BMC Microbiol] 2012 Sep 04; Vol. 12, pp. 191. Date of Electronic Publication: 2012 Sep 04.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Drug Resistance, Bacterial*
    Mutation, Missense*
    Antitubercular Agents/*pharmacology
    Mycobacterium tuberculosis/*drug effects
    Mycobacterium tuberculosis/*genetics
    Tuberculosis/*microbiology
    Bacterial Proteins/genetics ; Microbial Sensitivity Tests ; Mycobacterium tuberculosis/isolation & purification ; Papua New Guinea ; Pilot Projects
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Monitoring of malaria parasite resistance to chloroquine and sulphadoxine-pyrimethamine in the Solomon Islands by DNA microarray technology.
    Autorzy:
    Ballif M; Swiss Tropical and Public Health Institute, Department of Medical Parasitology and Biology of Infection, Department of Epidemiology and Public Health, Socinstrasse 57, 4002 Basel, Switzerland.
    Hii J
    Marfurt J
    Crameri A
    Fafale A
    Felger I
    Beck HP
    Genton B
    Pokaż więcej
    Źródło:
    Malaria journal [Malar J] 2010 Oct 06; Vol. 9, pp. 270. Date of Electronic Publication: 2010 Oct 06.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Antimalarials/*pharmacology
    Chloroquine/*pharmacology
    Malaria, Falciparum/*parasitology
    Oligonucleotide Array Sequence Analysis/*methods
    Plasmodium falciparum/*drug effects
    Pyrimethamine/*pharmacology
    Sulfadoxine/*pharmacology
    Adolescent ; Adult ; Aged ; Antimalarials/therapeutic use ; Child ; Child, Preschool ; Drug Combinations ; Female ; Gene Frequency ; Haplotypes ; Humans ; Infant ; Male ; Melanesia ; Middle Aged ; Mutation, Missense ; Parasitic Sensitivity Tests/methods ; Plasmodium falciparum/genetics ; Polymorphism, Single Nucleotide ; Protozoan Proteins/genetics ; Pyrimethamine/therapeutic use ; Sulfadoxine/therapeutic use ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007.
    Autorzy:
    Ballif M; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
    Ledergerber B
    Battegay M
    Cavassini M
    Bernasconi E
    Schmid P
    Hirschel B
    Furrer H
    Rickenbach M
    Opravil M
    Weber R
    Pokaż więcej
    Corporate Authors:
    Swiss HIV Cohort Study
    Źródło:
    PloS one [PLoS One] 2009 Dec 14; Vol. 4 (12), pp. e8275. Date of Electronic Publication: 2009 Dec 14.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Medication Adherence*
    Anti-Retroviral Agents/*therapeutic use
    HIV Infections/*drug therapy
    Adult ; Anti-Retroviral Agents/pharmacology ; Cohort Studies ; Drug Therapy, Combination ; Female ; Follow-Up Studies ; HIV-1/drug effects ; Humans ; Male ; Middle Aged ; Patient Selection ; RNA, Viral/genetics ; Switzerland ; Treatment Failure ; Viral Load/drug effects
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-19 z 19

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies